UroLift System TOlerability and ReCovery When Administering Local Anesthesia
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
The purpose of the study is to evaluate procedure tolerability and surgical recovery
 following the UroLift® system procedure when conducted with local anesthesia in subjects with
 symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at
 the Quality of Recovery Visual Analog Scale (QoR VAS) by the one month follow-up visit.
The randomized portion of the study is a prospective, multicenter, non-blinded, single arm
 trial evaluating procedure tolerability and surgical recovery following the UroLift® system
 procedure when conducted with local anesthesia. All subjects undergo UroLift system treatment
 and will be followed through 5 years after receiving the investigational device.
Inclusion Criteria:

 -  Males age of 50 years or older diagnosed with symptomatic benign prostatic hyperplasia
 (BPH)

 Exclusion Criteria:

 -  Size, volume,length of prostate